Abstract
The CellCard™ system enables the analysis of multiple cell types within a single microtiter well. In doing so, the CellCard system not only determines the effect of an experimental condition on a cell type of interest, but also the relative selectivity of that response across nine other cell types. In addition, this approach of cellular multiplexing is a means of miniaturization without the necessity of microfluidic devices. The standard 96-well plate generates ten 96-well plates of data (or, the equivalent of a 960-well plate). Taken together, the CellCard technology enables multiple cell types to be assayed within a single microtiter well allowing for the simultaneous determination of cellular activity and compound selectivity. This chapter will describe a method by which multiple cell types can be simultaneously assayed for biological parameters of interest.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abraham, V. C., Taylor, D. L., Haskins, J. R. (2004) High content screening applied to large-scale cell biology. Trends Biotechnol. 22(1), 15–22.
Giuliano, K. A., Haskins, J. R., Taylor, D. L. (2003) Advances in high content screening for drug discovery. Assay Drug Dev. Technol. 1(4), 565–577.
Liptrot, C. (2001) High content screening—from cells to data to knowledge. Drug Discov. Today 6(16), 832–834.
Arnould, R., Dubois, J., Abikhalil, F., et al. (1990) Comparison of two cytotoxicity assays—tetrazolium derivative reduction (MTT) and tritiated thymidine uptake—on three malignant mouse cell lines using chemotherapeutic agents and investigational drugs. Anticancer Res. 10(1), 145–154.
Rausch, O. (2005) Use of high content analysis for compound screening and target selection. IDrugs 8(7), 573–577.
Perlman, Z. E., Mitchison, T. J., Mayer, T. U. (2005) High content screening and profiling of drug activity in an automated centrosome-duplication assay. Chembiochem. 6(2), 218.
Borchert, K. M., Galvin, R. J., Frolik, C. A. (2005) High content screening assay for activators of the Wnt/Fzd pathway in primary human cells. Assay Drug Dev. Technol. 3(2), 133–141.
Vogt, A., Cooley, K. A., Brisson, M., Tarpley, M. G., Wipf, P., and Lazo, J. S. (2003) Cell-active dual specificity phosphatase inhibitors identified by high content screening. Chem. Biol. 10(8), 733–742.
Beske, O., Guo, J., Li, J., et al. (2004) A novel encoded particle technology that enables simultaneous interrogation of multiple cell types. J. Biomol. Screen 9(3), 173–185.
Beske, O. A. G. (2002) High-thgoughput cell analysis using multiplexed array technologies. Drug Discov. Today 7(18), S131–S135.
Beske, O., Goldbard, S., and Turpin, P. (2005) The CellCard System; a novel approach to assessing compound selectivity for lead prioritization. Combinatorial Chemistry High-Throughput Screen 8(4), 293–299.
Borchert, K. M., Galvin, R. J., Frolik, C. A., et al. (2005) High content screening assay for activators of the Wnt/Fzd pathway in primary human cells. Assay Drug Dev. Technol. 3(2), 133–141.
Di Nicolantonio, F., Knight, L. A., Whitehouse, P. A., et al. (2004). The ex vivo characterization of XR5944 (MLN944) against a panel of human clinical tumor samples. Mol. Cancer Ther. 3(12), 1631–1637.
Terashima, M., Hayashi, K., Fukushima, M., et al. (1996). Drug sensitivity testing for clinical samples from oesophageal cancer using adhesive tumour cell culture system. Br. J. Cancer 74(1), 73–77.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press, Inc.
About this protocol
Cite this protocol
Beske, O., Bassoni, D., Goldbard, S. (2007). Use of the CellCard™ System for Analyzing Multiple Cell Types in Parallel. In: Taylor, D.L., Haskins, J.R., Giuliano, K.A. (eds) High Content Screening. Methods in Molecular Biology, vol 356. Humana Press. https://doi.org/10.1385/1-59745-217-3:129
Download citation
DOI: https://doi.org/10.1385/1-59745-217-3:129
Publisher Name: Humana Press
Print ISBN: 978-1-58829-731-0
Online ISBN: 978-1-59745-217-5
eBook Packages: Springer Protocols